4.7 Meeting Abstract

A NOVEL LONG-ACTING INTERLEUKIN-7 AGONIST, NT-I7, INCREASES CYTOTOXIC CD8+T CELLS AND ENHANCES SURVIVAL IN MOUSE GLIOMA MODELS

Journal

JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume 8, Issue -, Pages A340-A340

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jitc-2020-SITC2020.0565

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available